Effects of tacrolimus ointment on type I (immediate and late) and IV (delayed) cutaneous allergic reactions in mice

Folia Pharmacologica Japonica

Volumn 112, Issue 3, 1998, Pages 221-232

  Sengoku, Takanori ^a   Morita, Kyoko ^a   Sato, Sachio ^a   Sakuma, Shozo ^a   Ogawa, Toshikazu ^a   Hiroi, Jun ^a   Fujii, Takashi ^a   Goto, Toshio ^a  

^a ASTELLAS PHARMA INC   (Japan)

Author keywords

Atopic dermatitis; Steroid ointment; Tacrolimus ointment; Type I cutaneous allergic reaction; Type IV cutaneous allergic reaction

Indexed keywords

ALCLOMETASONE DIPROPIONATE; BETAMETHASONE VALERATE; DIPHENHYDRAMINE; TACROLIMUS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DELAYED HYPERSENSITIVITY; DRUG EFFECT; DRUG POTENCY; EAR; EDEMA; IMMEDIATE TYPE HYPERSENSITIVITY; MOUSE; NONHUMAN; OINTMENT; SKIN ALLERGY; SKINFOLD THICKNESS; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

EID: 0031719001     PISSN: 00155691     EISSN: None     Source Type: Journal    
DOI: 10.1254/fpj.112.221     Document Type: Article

References (36)

1. Kino T, Hatanaka H, Hashimoto M, Nishiyama M, Goto T, Okuhara M, Kohsaka M, Aoki H and Imanaka H: FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics. J Antibiot 40, 1249-1255 (1987)
2. Kino T, Hatanaka H, Miyata S, Inamura N, Nishiyama M, Yajima T, Goto T, Okuhara M, Kohsaka M, Aoki H, et al: FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro. J Antibiot 40, 1256-1265 (1987)
3. Ochiai T, Nakajima K, Nagata M, Hori S, Asano T and Isono K: Studies of the induction and maintenance of long-term graft acceptance by treatment with FK506 in heterotopic cardiac allotransplantation in rats. Transplantation 44, 734-738 (1987)
4. Murase N, Todo S, Lee P-H, Lai H-S, Chapman F, Nalesnik MA, Makowka L and Starzl TE: Heterotopic heart transplantation in the rat receiving FK-506 alone or with cyclosporine. Transplant Proc 19, 71-75 (1987)
5. Ochiai T, Nagata M, Nakajima K, Suzuki T, Sakamoto K, Enomoto K, Gunji Y, Uematsu T, Goto T, Hori S, et al: Studies of the effects of FK 506 on renal allografting in the beagle dog. Transplantation 44, 729-733 (1987)
6. Todo S, Demetris AJ, Ueda Y, Imventarza O, Okuda K, Casavilla A, Cemaj S, Ghalab A, Mazzaferro V, Rhoe BS, et al: Canine kidney transplantation with FK-506 alone or in combination with cyclosporine and steroids. Transplant Proc 19, 57-61 (1987)
7. Todo S, Podesta L, ChapChap P, Kahn D, Pan C-E, Ueda Y, Okuda K, Imventarza O, Casavilla A, Demetris AJ, et al: Orthotopic liver transplantation in dogs receiving FK-506. Transplant Proc 19, 64-67 (1987)
8. Monden M, Gotoh M, Kanai T, Valdivia LA, Umeshita K, Endoh W, Nakano Y, Kawai M, Ohzato H, Ukei T, et al: A potent immunosuppressive effect of FK 506 in orthotopic liver transplan-tation in primates. Transplant Proc 22, 66-71 (1990)
9. Inamura N, Nakahara K, Kino T, Goto T, Aoki H, Yamaguchi I, Kohsaka M and Ochiai T: Prolongation of skin allograft survival in rats by a novel immunosuppressive agent, FK506. Transplantation 45, 206-209 (1988)
10. Inamura N, Hashimoto M, Nakahara K, Aoki H, Yamaguchi I and Kohsaka M: Immunosuppressive effect of FK 506 on collagen-induced arthritis in rats. Clin Immunol Immunopathol 46, 82-90 (1988)
11. Inamura N, Hashimoto M, Nakahara K, Nakajima Y, Nishio M, Aoki H, Yamaguchi I and Kohsaka M: Immunosuppressive effect of FK506 on experimental allergic encephalomyelitis in rats. Int J Immunopharmacol 10, 991-995 (1988)
12. Takabayashi K, Koike T, Kurasawa K, Matsumura R, Sato T, Tomioka H, Ito I, Yoshiki T and Yoshida S: Effect of FK-506, a novel immunosuppressive drug on murine systemic lupus erythematosus. Clin Immunol Immunopathol 51, 110-117 (1989)
13. Ohara K, Billington R, James RW, Dean GA, Nishiyama M and Noguchi H: Toxicologic evaluation of FK 506. Transplant Proc 22, 83-86 (1990)
14. Fung JJ, Todo S, Jain A, McCauley J, Alessiani M, Scotti C and Starzl TE: Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications. Transplant Proc 22, 6-12 (1990)
15. Grewe M, Gyufko K, Schöpf E and Krutmann J: Lesional expression of interferon-γ in atopic eczema. Lancet 343, 25-26 (1994)
16. Thepen T, Langeveld-Wildschut EG, Bihari IC, van Wichen DF, van Reijsen FC, Mudde GC and Bruijnzeel-Koomen CAFM : Biphasic response against aeroallergen in atopic dermatitis showing a switch from an initial TH2 response to a TH1 response in situ: An immunocytochemical study. J Allergy Clin Immunol 97, 828-837 (1996)
17. Grewe M, Walther S, Gyufko K, Czech W, Schöpf E and Krutmann J: Analysis of the cytokine pattern expressed in situ in inhalant allergen patch test reactions of atopic dermatitis patients. J Invest Dermatol 105, 407-410 (1995)
18. Inagaki N, Goto S, Nagai H and Koda A: Pharmacological characterization of mouse ear PCA. Int Arch Allergy Appl Immunol 78, 113-117 (1985)
19. Kapsenberg ML, Wierenga EA, Bos JD and Jansen HM: Functional subsets of allergen-reactive human CD4* T cells. Immunol Today 12, 392-395 (1991)
20. Hamid Q, Boguniewicz M and Leung DYM: Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis. J Clin Invest 94, 870-876 (1994)
21. Medicina 34, 220-223 (1997)
22. de Paulis A, Stellato C, Cirillo R, Ciccarelli A, Oriente A and Marone G: Anti-inflammatory effect of FK-506 on human skin mast cells. J Invest Dermatol 99, 723-728 (1992)
23. Katayama I, Otoyama K, Yokozeki H and Nishioka K: Effect of mast cell modulators on IgE-mediated murine biphasic cutaneous reactions. Int Arch Allergy Immunol 109, 390-397 (1996)
24. Asherson GL and Ptak W: Contact and delayed hypersensitivity in the mouse. I. Active sensitization and passive transfer. Immunology 15, 405-416 (1968)
25. Kuriki H, Saijo T, Ashida Y and Maki Y: Effect of 6-ethyl-3-(1H-tetrazol-5-yl) chromone (AA-344) on the immediate and delayed hypersensitivity reactions. Jpn J Pharmacol 29, 733-744 (1979)
26. Ohmen JD, Hanifin JM, Nickoloff BJ, Rea TH, Wyzykowski R, Kim J, Jullien D, McHugh T, Nassif AS, Chan SC, et al: Overexpression of IL-10 in atopic dermatitis. Contrasting cytokine patterns with delayed-type hypersensitivity reactions. J Immunol 154, 1956-1963 (1995)
27. Betamethasone butyrate propionate (TO-186) 6, 1683-1692 (1990)
28. Grabbe S, Steinbrink K, Steinert M, Luger TA and Schwarz T: Removal of the majority of epidermal Langerhans cells by topical or systemic steroid application enhances the effector phase of murine contact hypersensitivity. J Immunol 155, 4207-4217 (1995)